Coherus BioSciences (CHRS) has a market capitalization of $129.8M, based on 118M shares at a price of $1.10 (down 0.9% today).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
February 2025 | $1.10 | 15,221,331 | 117,997,091 | $129,796,800.10 |
January 2025 | $1.18 | 50,094,933 | 117,997,091 | $139,236,567.38 |
December 2024 | $1.38 | 191,064,531 | 115,210,100 | $158,989,938.00 |
November 2024 | $1.22 | 78,583,999 | 115,210,100 | $140,556,322.00 |
October 2024 | $0.75 | 61,411,019 | 115,210,100 | $85,831,524.50 |
September 2024 | $1.04 | 44,657,146 | 115,210,100 | $119,818,504.00 |
August 2024 | $1.39 | 42,496,223 | 115,210,100 | $160,142,039.00 |
July 2024 | $1.54 | 37,342,311 | 115,210,100 | $177,423,554.00 |
June 2024 | $1.73 | 30,080,657 | 114,820,000 | $198,638,600.00 |
May 2024 | $1.82 | 37,796,830 | 114,820,000 | $208,972,400.00 |
April 2024 | $1.96 | 36,187,880 | 114,820,000 | $225,047,200.00 |
March 2024 | $2.39 | 61,054,008 | 125,530,000 | $300,016,700.00 |
February 2024 | $2.28 | 59,128,805 | 125,530,000 | $286,208,400.00 |
January 2024 | $2.15 | 145,580,088 | 125,530,000 | $269,889,500.00 |
December 2023 | $3.33 | 169,609,031 | 111,492,600 | $371,270,358.00 |
November 2023 | $2.13 | 119,980,449 | 111,492,600 | $237,479,238.00 |
October 2023 | $3.35 | 84,495,372 | 111,492,600 | $373,500,210.00 |
September 2023 | $3.74 | 77,774,160 | 97,738,500 | $365,541,990.00 |
August 2023 | $5.33 | 50,181,368 | 97,738,500 | $520,946,205.00 |
July 2023 | $4.82 | 60,380,319 | 97,738,500 | $471,099,570.00 |
June 2023 | $4.27 | 98,896,852 | 87,269,600 | $372,641,192.00 |
May 2023 | $4.09 | 66,020,486 | 87,269,600 | $356,932,664.00 |
April 2023 | $7.23 | 15,621,431 | 87,269,600 | $630,959,208.00 |
March 2023 | $6.84 | 29,300,899 | 79,268,900 | $542,199,276.00 |
February 2023 | $6.77 | 15,868,847 | 79,268,900 | $536,650,453.00 |
